Prevalence rates at enrolment and incidence rates during 12 months of follow up of stavudine associated toxicities in 253 Malawian adults.

*Prevalence at enrolment i.e. after one year of stavudine containing ART.¶One or more of peripheral neuropathy, lipodystrophy, pancreatitis, hyperlactate syndrome, diabetes mellitus.†severe hyperlactatemia, symptomatic hyperlactatemia and lactic acidosis, as defined in methods paragraph.IR, incidence rate; PR, prevalence rate; CI, confidence interval; py, person-years; TC, total cholesterol serum level; TG, triglyceride serum level.